[
    [
        {
            "time": "",
            "original_text": "【国信医药】康泰生物：业绩持续回暖，四价苗恢复增长（三季报点评）",
            "features": {
                "keywords": [
                    "康泰生物",
                    "业绩持续回暖",
                    "四价苗",
                    "恢复增长",
                    "三季报"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【国信医药】康泰生物：业绩持续回暖，四价苗恢复增长（三季报点评）",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]